We partner with the media to inform the public of the global human crisis.
July 31, 2017Indivior RBP-6000 NDA Acceptance with Priority Review Designation...
July 31, 2017Indivior’s NALSCUE® Receives Marketing Authorization from French Regulatory Agency ANSM...
July 27, 2017Indivior H1 2017 Financial Results...
July 13, 2017Indivior to Announce Half Year 2017 Results on July 27th...
June 29, 2017Reminder RBP-6000 Investor Event Announcement...
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline